Skip to content

A study for Clinical application of optimized corpus luteum support program after embryo transfer

A study for Clinical application of optimized corpus luteum support program after embryo transfer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020342
Enrollment
Unknown
Registered
2018-12-25
Start date
2019-01-10
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Group 1:on the basis of conventional luteal support treatment plus the addition of estradiol valerate 4mg / d orally, until HCG blood test day.
Group 2:On the third day of the membrane transformation day, HCG2000IU was administered intramuscularly once every other day for 5 consecutive times.

Sponsors

Northwest Women's and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. The inclusion criterion: the patients use long luteal down-regulation protocol to stimulate ovarion undergone IVF/intracytoplasmic sperm injection (ICSI) with fresh ET,The percent of Serum estrogen levels decreased by >80% at 48 h after oocyte retrieval compared with hCG trigger day; 2. The inclusion criteria: female age under 40 years old; Frozen transplantation cycles with hormone replacement therapy preparation of endometrium (including GnRH-a cycles).

Exclusion criteria

Exclusion criteria: 1. The exclusion criterion: uterine malformations,endometriosis,and an endometrial thickness 5000 pg/mL. The patients were counseled and signed an informed consent. 2. The exclusion criterion: uterine malformations; endometriosis; endometrial thickness <8 mm; the follicle diameter =14cm on the secretory transformation day. The patients will be counseled and signed an informed consent.

Design outcomes

Primary

MeasureTime frame
Ongoing pregnancy rate;

Secondary

MeasureTime frame
plant rate;Early abortion rate;clinical pregnancy rate;ovarian hyperstimulation syndrome rate;

Countries

China

Contacts

Public ContactNa LI

Northwest Women's and Children's Hospital

linasmiling@126.com+86 13891949899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026